XT
FHTX icon

XTX Topco’s Foghorn Therapeutics FHTX Stock Holding History

XTX Topco’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,662
Closed -$84.6K – 3984
2025
Q4 		$84.6K Buy
+15,662
New +$71K ﹤0.01% 2679
2024
Q4 		– Sell
-10,900
Closed -$101K – 2469
2024
Q3 		$101K Buy
+10,900
New +$78.9K 0.01% 1604
2024
Q2 		– Sell
-13,448
Closed -$90.2K – 2051
2024
Q1 		$90.2K Buy
+13,448
New +$74.7K 0.01% 1383
2022
Q3 		– Sell
-11,436
Closed -$156K – 1179
2022
Q2 		$156K Buy
+11,436
New +$148K 0.06% 532

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

XTX Topco's FHTX Position: Q1 2026 in Review

XTX Topco sold out of Foghorn Therapeutics (FHTX) in Q1 2026, closing a stake of 15,662 shares — an estimated $84.6K sold.

XTX Topco first reported a position in FHTX in Q2 2022 and held it in 4 quarters. The position peaked at $156K in Q2 2022. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • XTX Topco reported no remaining Foghorn Therapeutics position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 15,662 Foghorn Therapeutics shares in Q1 2026, an estimated $84.6K.
  • XTX Topco first reported a position in Foghorn Therapeutics in Q2 2022 and held it in 4 quarters.
  • XTX Topco's Foghorn Therapeutics position peaked at $156K in Q2 2022.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.